Log in to save to my catalogue

Dapagliflozin-induced abnormal uterine bleeding in a patient with dilated cardiomyopathy and chronic...

Dapagliflozin-induced abnormal uterine bleeding in a patient with dilated cardiomyopathy and chronic...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9e45a18a32bd4c35a5698873864777d2

Dapagliflozin-induced abnormal uterine bleeding in a patient with dilated cardiomyopathy and chronic heart failure: a case report

About this item

Full title

Dapagliflozin-induced abnormal uterine bleeding in a patient with dilated cardiomyopathy and chronic heart failure: a case report

Publisher

London, England: SAGE Publications

Journal title

Journal of international medical research, 2024-08, Vol.52 (8), p.3000605241271750

Language

English

Formats

Publication information

Publisher

London, England: SAGE Publications

More information

Scope and Contents

Contents

Sodium-glucose cotransporter-2 (SGLT2) inhibitors are extensively used in the management of heart failure because of their cardiovascular benefits. Adverse drug reactions associated with dapagliflozin include diabetic ketoacidosis, fungal infections, and increased blood glucose concentrations. However, abnormal uterine bleeding is not a known side...

Alternative Titles

Full title

Dapagliflozin-induced abnormal uterine bleeding in a patient with dilated cardiomyopathy and chronic heart failure: a case report

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9e45a18a32bd4c35a5698873864777d2

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9e45a18a32bd4c35a5698873864777d2

Other Identifiers

ISSN

0300-0605,1473-2300

E-ISSN

1473-2300

DOI

10.1177/03000605241271750

How to access this item